Publications

1. Agyare EK, Leonard SR, Curran GL, Yu CC, Lowe VJ, Paravastu AK, Poduslo JF, Kandimalla KK. Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-beta proteins in the cerebral vasculature. Molecular Pharmaceutics. 2013; 10(5):1557-65. 2326359
   
2. Poduslo JF, Howell KG, Olson NC, Ramirez-Alvarado M, Kandimalla KK. Alzheimer's disease amyloid beta-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils. Biochemistry. 2012 May 15; 51(19):3993-4003. Epub 2012 May 07. 2243877
   View PubMed
3. Murphy MC, Curran GL, Glaser KJ, Rossman PJ, Huston J 3rd, Poduslo JF, Jack CR Jr, Felmlee JP, Ehman RL. Magnetic resonance elastography of the brain in a mouse model of Alzheimer's disease: initial results. Magn Reson Imaging. 2012 May; 30(4):535-9. Epub 2012 Feb 10. 2224211
   View PubMed
4. Jaruszewski KM, Ramakrishnan S, Poduslo JF, Kandimalla KK. Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer's disease amyloid protein. Nanomedicine. 2012 Feb; 8(2):250-60. Epub 2011 Jun 24. 2225302
   View PubMed
5. Trushina E, Nemutlu E, Zhang S, Christensen T, Camp J, Mesa J, Siddiqui A, Tamura Y, Sesaki H, Wengenack TM, Dzeja PP, Poduslo JF. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease. PLoS One. 2012; 7(2):e32737. Epub 2012 Feb 29. 2228963
   View PubMed
6. Omtri RS, Davidson MW, Arumugam B, Poduslo JF, Kandimalla KK. Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: Ramifications for the Alzheimer's drug discovery. Molecular Pharmaceutics. 2012; 9(7):1887-97. 2261922
   
7. Poduslo JF, Hultman KL, Curran GL, Preboske GM, Chamberlain R, Marjanska M, Garwood M, Jack CR Jr, Wengenack TM. Targeting vascular amyloid in arterioles of Alzheimer disease transgenic mice with amyloid beta protein antibody-coated nanoparticles. J Neuropathol Exp Neurol. 2011 Aug; 70(8):653-61. 2178154
   View PubMed
8. Chamberlain R, Wengenack TM, Poduslo JF, Garwood M, Jack CR Jr. Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease. Curr Med Imaging Rev. 2011 Feb; 7(1):3-7. 2153544
   View PubMed
9. Wengenack TM, Reyes DA, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Gilles EJ, Chamberlain R, Marjanska M, Jack CR Jr, Garwood M, Poduslo JF. Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain. Neuroimage. 2011 Jan 1; 54(1):113-22. Epub 2010 Aug 20. 2111507
   View PubMed
10. Sarkar G, Curran GL, Mahlum E, Decklever T, Wengenack TM, Blahnik A, Hoesley B, Lowe VJ, Poduslo JF, Jenkins RB. A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brain. PLoS One. 2011; 6(12):e28881. Epub 2011 Dec 21. 2215199
    View PubMed
11. Poduslo JF, Gilles EJ, Ramakrishnan M, Howell KG, Wengenack TM, Curran GL, Kandimalla KK. HH domain of Alzheimer's disease Abeta provides structural basis for neuronal binding in PC12 and mouse cortical/hippocampal neurons. PLoS One. 2010; 5(1):e8813. Epub 2010 Jan 21. 1982475
    View PubMed
12. Ramakrishnan M, Kandimalla KK, Wengenack TM, Howell KG, Poduslo JF. Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies. Biochemistry. 2009 Nov 3; 48(43):10405-15. 1967165
    View PubMed
13. Chamberlain R, Reyes D, Curran GL, Marjanska M, Wengenack TM, Poduslo JF, Garwood M, Jack CR Jr. Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease. Magn Reson Med. 2009 May; 61(5):1158-64. 1937952
    View PubMed
14. Yao JK, Wengenack TM, Curran GL, Poduslo JF. Reduced membrane lipids in the cortex of Alzheimer's disease transgenic mice. Neurochem Res. 2009 Jan; 34(1):102-8. Epub 2008 Mar 29. 1951135
    View PubMed
15. Kandimalla KK, Scott OG, Fulzele S, Davidson MW, Poduslo JF. Mechanism of neuronal versus endothelial cell uptake of Alzheimer's disease amyloid beta protein. PLoS One. 2009; 4(2):e4627. Epub 2009 Feb 27. 1964955
    View PubMed
16. Agyare EK, Curran GL, Ramakrishnan M, Yu CC, Poduslo JF, Kandimalla KK. Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy. Pharm Res. 2008 Nov; 25(11):2674-84. Epub 2008 Aug 20. 1937949
    View PubMed
17. Ramakrishnan M, Wengenack TM, Kandimalla KK, Curran GL, Gilles EJ, Ramirez-Alvarado M, Lin J, Garwood M, Jack CR Jr, Poduslo JF. Selective contrast enhancement of individual Alzheimer's disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Abeta42 for magnetic resonance molecular imaging. Pharm Res. 2008 Aug; 25(8):1861-72. Epub 2008 Apr 29. 1902523
    View PubMed
18. Wengenack TM, Jack CR Jr, Garwood M, Poduslo JF. MR microimaging of amyloid plaques in Alzheimer's disease transgenic mice. Eur J Nucl Med Mol Imaging. 2008 Mar; 35 Suppl 1:S82-8. 1879472
    View PubMed
19. Kandimalla KK, Wengenack TM, Curran GL, Gilles EJ, Poduslo JF. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. J Pharmacol Exp Ther. 2007 Aug; 322(2):541-9. Epub 2007 May 15. 1837065
    View PubMed
20. Poduslo JF, Ramakrishnan M, Holasek SS, Ramirez-Alvarado M, Kandimalla KK, Gilles EJ, Curran GL, Wengenack TM. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques. J Neurochem. 2007 Jul; 102(2):420-33. 1834796
    View PubMed
21. Hartman TK, Wengenack TM, Poduslo JF, van Deursen JM. Mutant mice with small amounts of BubR1 display accelerated age-related gliosis. Neurobiol Aging. 2007 Jun; 28(6):921-7. Epub 2006 Jun 15. 1818732
    View PubMed
22. Jack CR Jr, Marjanska M, Wengenack TM, Reyes DA, Curran GL, Lin J, Preboske GM, Poduslo JF, Garwood M. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Neuroscientist. 2007 Feb; 13(1):38-48. 1812021
    View PubMed
23. Kandimalla KK, Curran GL, Holasek SS, Gilles EJ, Wengenack TM, Ramirez-Alvarado M, Poduslo JF. Physiological and biophysical factors that influence Alzheimer's disease amyloid plaque targeting of native and putrescine modified human amyloid beta40. J Pharmacol Exp Ther. 2006 Jul; 318(1):17-25. Epub 2006 Mar 24. 1769972
    View PubMed
24. Jack CR Jr, Wengenack TM, Reyes DA, Garwood M, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Adriany G, Poduslo JF. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J Neurosci. 2005 Oct 26; 25(43):10041-8. 1962205
    View PubMed
25. Marjanska M, Curran GL, Wengenack TM, Henry PG, Bliss RL, Poduslo JF, Jack CR, Ugurbil K, Garwood M. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A. 2005 Aug 16; 102(33):11906-10. 1730017
    View PubMed
26. Kandimalla KK, Curran GL, Holasek SS, Gilles EJ, Wengenack TM, Poduslo JF. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation. J Pharmacol Exp Ther. 2005 Jun; 313(3):1370-8. Epub 2005 Mar 02. 1716410
    View PubMed
27. Holasek SS, Wengenack TM, Kandimalla KK, Montano C, Gregor DM, Curran GL, Poduslo JF. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice. Brain Res. 2005 May 31; 1045(1-2):185-98. Epub 2005 Apr 25. 1720450
    View PubMed
28. Jack CR Jr, Garwood M, Wengenack TM, Borowski B, Curran GL, Lin J, Adriany G, Grohn OH, Grimm R, Poduslo JF. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med. 2004 Dec; 52(6):1263-71. 1674500
    View PubMed
29. Wengenack TM, Holasek SS, Montano CM, Gregor D, Curran GL, Poduslo JF. Activation of programmed cell death markers in ventral horn motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in a transgenic mouse model. Brain Res. 2004 Nov 19; 1027(1-2):73-86. 1674069
    View PubMed
30. Poduslo JF, Curran GL, Peterson JA, McCormick DJ, Fauq AH, Khan MA, Wengenack TM. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques. Biochemistry. 2004 May 25; 43(20):6064-75. 1647050
    View PubMed
31. Poduslo JF, Wengenack TM, Curran GL, Wisniewski T, Sigurdsson EM, Macura SI, Borowski BJ, Jack CR Jr. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis. 2002 Nov; 11(2):315-29. 1317745
    View PubMed
32. Poduslo JF, Curran GL. Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier. Neuroreport. 2001 Oct 29; 12(15):3197-200. 1006612
    View PubMed
33. Poduslo JF, Curran GL, Wengenack TM, Malester B, Duff K. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease. Neurobiol Dis. 2001 Aug; 8(4):555-67. 1014890
    View PubMed
34. Poduslo JF, Whelan SL, Curran GL, Wengenack TM. Therapeutic benefit of polyamine-modified catalase as a scavenger of hydrogen peroxide and nitric oxide in familial amyotrophic lateral sclerosis transgenics. Ann Neurol. 2000 Dec; 48(6):943-7. 1013645
    View PubMed
35. Wengenack TM, Curran GL, Poduslo JF. Targeting alzheimer amyloid plaques in vivo. Nat Biotechnol. 2000 Aug; 18(8):868-72. 1012725
    View PubMed
36. Burguera B, Couce ME, Curran GL, Jensen MD, Lloyd RV, Cleary MP, Poduslo JF. Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes. 2000 Jul; 49(7):1219-23. 135007
    View PubMed
37. Wengenack TM, Whelan S, Curran GL, Duff KE, Poduslo JF. Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain. Neuroscience. 2000; 101(4):939-44. 1013678
    View PubMed
38. Reinholz MM, Merkle CM, Poduslo JF. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis. Exp Neurol. 1999 Sep; 159(1):204-16. 1009111
    View PubMed
39. Reinholz MM, Haggard JJ, Curran GL, Poduslo JF. Plasma pharmacokinetics, nervous system biodistribution and biostability, and spinal cord permeability at the blood-brain barrier of putrescine- modified catalase in the adult rat. Exp Neurol. 1999 Sep; 159(1):191-203. 1009441
    View PubMed
40. Poduslo JF, Curran GL, Kumar A, Frangione B, Soto C. Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma. J Neurobiol. 1999 Jun 5; 39(3):371-82. 1008963
    View PubMed
41. Poduslo JF, Curran GL, Sanyal B, Selkoe DJ. Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier. Neurobiol Dis. 1999 Jun; 6(3):190-9. 1009110
    View PubMed
42. Poduslo JF, Curran GL, Gill JS. Putrescine-modified nerve growth factor: bioactivity, plasma pharmacokinetics, blood-brain/nerve barrier permeability, and nervous system biodistribution. J Neurochem. 1998 Oct; 71(4):1651-60. 1019617
    View PubMed
43. Walikonis RS, Poduslo JF. Activity of cyclic AMP phosphodiesterases and adenylyl cyclase in peripheral nerve after crush and permanent transection injuries. J Biol Chem. 1998 Apr 10; 273(15):9070-7. 1018691
    View PubMed
44. Wengenack TM, Curran GL, Olson EE, Poduslo JF. Putrescine-modified catalase with preserved enzymatic activity exhibits increased permeability at the blood-nerve and blood-brain barriers. Brain Res. 1997 Aug 29; 767(1):128-35. 1016033
    View PubMed
45. Wengenack TM, Curran GL, Poduslo JF. Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia. Brain Res. 1997 Apr 18; 754(1-2):46-54. 1016804
    View PubMed
46. Poduslo JF, Curran GL, Haggard JJ, Biere AL, Selkoe DJ. Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier. Neurobiol Dis. 1997; 4(1):27-34. 1015769
    View PubMed
47. Poduslo JF, Curran GL. Increased permeability of superoxide dismutase at the blood-nerve and blood-brain barriers with retained enzymatic activity after covalent modification with the naturally occurring polyamine, putrescine. J Neurochem. 1996 Aug; 67(2):734-41. 1025729
    View PubMed
48. Poduslo JF, Curran GL. Polyamine modification increases the permeability of proteins at the blood-nerve and blood-brain barriers. J Neurochem. 1996 Apr; 66(4):1599-609. 1025314
    View PubMed
49. Poduslo JF, Curran GL. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res. 1996 Mar; 36(2):280-6. 1025417
    View PubMed
50. Poduslo JF, Walikonis RS, Domec MC, Berg CT, Holtz-Heppelmann CJ. The second messenger, cyclic AMP, is not sufficient for myelin gene induction in the peripheral nervous system. J Neurochem. 1995 Jul; 65(1):149-59. 1023784
    View PubMed
51. Poduslo JF, Curran GL, Berg CT. Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc Natl Acad Sci U S A. 1994 Jun 7; 91(12):5705-9. 1032228
    View PubMed
52. Poduslo JF, Curran GL. Glycation increases the permeability of proteins across the blood-nerve and blood-brain barriers. Brain Res Mol Brain Res. 1994 Apr; 23(1-2):157-62. 1032216
    View PubMed
53. Gupta SK, Pringle J, Poduslo JF, Mezei C. Induction of myelin genes during peripheral nerve remyelination requires a continuous signal from the ingrowing axon. J Neurosci Res. 1993 Jan; 34(1):14-23. 1031298
    View PubMed
54. Low PA, Kihara M, Cameron N, Cotter M, Poduslo JF. Cause and effect of ischemia in chronic experimental diabetic neuropathy. Diabet Med. 1993; 10(Suppl 2):52S-55S. 1030267
    View PubMed
55. Podratz JL, Windebank AJ, Poduslo JF. Dialyzer associated neurotoxicity due to a change in fatty acid structure. Trans Am Soc Neurochem. 1993; 24:229. 1194580
    
56. LeBlanc AC, Pringle J, Lemieux J, Poduslo JF, Mezei C. Regulation of 2',3'-cyclic nucleotide phosphodiesterase gene expression in experimental peripheral neuropathies. Brain Res Mol Brain Res. 1992 Sep; 15(1-2):40-6. 1028303
    View PubMed
57. Poduslo JF, Curran GL. Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy. Proc Natl Acad Sci U S A. 1992 Mar 15; 89(6):2218-22. 1039667
    View PubMed
58. LeBlanc AC, Windebank AJ, Poduslo JF. P0 gene expression in Schwann cells is modulated by an increase of cAMP which is dependent on the presence of axons. Brain Res Mol Brain Res. 1992 Jan; 12(1-3):31-8. 1028292
    View PubMed
59. Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nickander KK, Low PA. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci U S A. 1991 Jul 15; 88(14):6107-11. 1037807
    View PubMed
60. Gupta SK, Pringle J, Poduslo JF, Mezei C. Levels of proteolipid protein mRNAs in peripheral nerve are not under stringent axonal control. J Neurochem. 1991 May; 56(5):1754-62. 1038954
    View PubMed
61. Yoshikawa H, Dyck PJ, Poduslo JF, Giannini C. Polyglucosan body axonal enlargement increases myelin spiral length but not lamellar number. J Neurol Sci. 1990 Aug; 98(1):107-17. 1034315
    View PubMed
62. LeBlanc AC, Poduslo JF. Axonal modulation of myelin gene expression in the peripheral nerve. J Neurosci Res. 1990 Jul; 26(3):317-26. 1036257
    View PubMed
63. Weerasuriya A, Curran GL, Poduslo JF. Development changes in blood-nerve transfer of albumin and endoneurial albumin content in rat sciatic nerve. Brain Res. 1990 Jun 25; 521:40-46. 1035509
    View PubMed
64. Brunden KR, Windebank AJ, Poduslo JF. Role of axons in the regulation of P0 biosynthesis by Schwann cells. J Neurosci Res. 1990 Jun; 26(2):135-43. 1036255
    View PubMed
65. Kohriyama T, Yu RK, Berg CT, Poduslo JF. Sulfate incorporation into peripheral nerve endoneurial glycolipids after crush and permanent transection injury. J Neurosci Res. 1990 Jun; 26(2):144-8. 1036256
    View PubMed
66. Weerasuriya A, Curran GL, Poduslo JF. Physiological changes in the sciatic nerve endoneurium of lead-intoxicated rats: a model of endoneurial homeostasis. Brain Res. 1990 May 28; 517(1-2):1-6. 1034802
    View PubMed
67. Poduslo JF. Golgi sulfation of the oligosaccharide chain of P0 occurs in the presence of myelin assembly but not in its absence. J Biol Chem. 1990 Mar 5; 265(7):3719-25. 1035507
    View PubMed
68. Yao JK, Windebank AJ, Poduslo JF, Yoshino JE. Axonal regulation of Schwann cell glycolipid biosynthesis. Neurochem Res. 1990 Mar; 15(3):279-82. 1036248
    View PubMed
69. LeBlanc AC, Poduslo JF. Regulation of apolipoprotein E gene expression after injury of the rat sciatic nerve. J Neurosci Res. 1990 Feb; 25(2):162-71. 1036247
    View PubMed
70. Brunden KR, Windebank AJ, Poduslo JF. Catabolic regulation of the expression of the major myelin glycoprotein by Schwann cells in culture. J Neurochem. 1990 Feb; 54(2):459-66. 1036214
    View PubMed
71. Brunden KR, Poduslo JF. Posttranslational degradation of the major myelin glycoprotein by Schwann cells in vivo and in vitro. Ann N Y Acad Sci. 1990; 605:230-9. 1036280
    View PubMed
72. Gupta SK, Poduslo JF, Dunn R, Roder J, Mezei C. Myelin-associated glycoprotein gene expression in the presence and absence of Schwann cell-axonal contact. Dev Neurosci. 1990; 12(1):22-33. 1036188
    View PubMed
73. Weerasuriya A, Curran GL, Poduslo JF. Blood-nerve transfer of albumin and its implications for the endoneurial microenvironment. Brain Res. 1989 Aug 7; 494(1):114-21. 1046556
    View PubMed
74. Costantino-Ceccarini E, Poduslo JF. Regulation of UDP-galactose: ceramide galactosyltransferase after crush and transection nerve injury. J Neurochem. 1989 Jul; 53:205-211. 1046817
    View PubMed
75. Dyck PJ, Zimmerman BR, Vilen TH, Minnerath SR, Karnes JL, Yao JK, Poduslo JF. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med. 1988 Sep 1; 319(9):542-8. 66023
    View PubMed
76. Gupta SK, Poduslo JF, Mezei C. Temporal changes in PO and MBP gene expression after crush-injury of the adult peripheral nerve. Brain Res. 1988 Sep; 464(2):133-41. 1044285
    View PubMed
77. Poduslo JF, Curran GL, Dyck PJ. Increase in albumin, IgG, and IgM blood-nerve barrier indices in human diabetic neuropathy. Proc Natl Acad Sci U S A. 1988 Jul; 85(13):4879-83. 1042527
    View PubMed
78. Poduslo JF, Curran GL, Brunden KR, Dyck PJ. IgM/IgG solid-phase antibody-capture assay with biotin/125I-streptavidin amplification: application to normal human sural nerve biopsies. J Neuroimmunol. 1988 May; 18(2):117-24. 1042160
    View PubMed
79. Poduslo JF. Control of myelin gene expression by Schwann cells. Trans Am Soc Neurochem. 1988 Mar 6-11; 19:152. 1044007
    
80. Yao JK, Poduslo JF. Biosynthesis of neutral glucocerebroside homologues in the absence of myelin assembly after nerve transection. J Neurochem. 1988 Feb; 50(2):630-8. 1044239
    View PubMed
81. Low PA, Schmelzer JD, Ward KK, Curran GL, Poduslo JF. Effect of hyperbaric oxygenation on normal and chronic streptozotocin diabetic peripheral nerves. Exp Neurol. 1988 Jan; 99(1):201-12. 1042469
    View PubMed
82. Brunden KR, Poduslo JF. A phorbol ester-sensitive kinase catalyzes the phosphorylation of P0 glycoprotein in myelin. J Neurochem. 1987 Dec; 49(6):1863-72. 1041013
    View PubMed
83. Brunden KR, Berg CT, Poduslo JF. Isolation of an integral membrane glycoprotein by chloroform-methanol extraction and C3-reversed-phase high-performance liquid chromatography. Anal Biochem. 1987 Aug 1; 164(2):474-81. 1041183
    View PubMed
84. LeBlanc AC, Poduslo JF, Mezei C. Gene expression in the presence or absence of myelin assembly. Brain Res. 1987 Apr; 388(1):57-67. 1041141
    View PubMed
85. Brunden KR, Poduslo JF. Lysosomal delivery of the major myelin glycoprotein in the absence of myelin assembly: posttranslational regulation of the level of expression by Schwann cells. J Cell Biol. 1987 Mar; 104(3):661-9. 1041137
    View PubMed
86. Windebank AJ, Poduslo JF. Neuronal growth factors produced by adult peripheral nerve after injury. Brain Res. 1986 Oct 15; 385(1):197-200. 1053364
    View PubMed
87. Poduslo JF. Regulation of Schwann cell expression of myelin-specific glycoconjugates. Adv Biosci. 1986; 61:311-321. 1053253
    
88. Ohi T, Poduslo JF, Dyck PJ. Increased endoneurial albumin in diabetic polyneuropathy. Neurology. 1985 Dec; 35(12):1790-1. 1049441
    View PubMed
89. Ohi T, Poduslo JF, Curran GL, Dyck PJ. Quantitative method for detection of blood-nerve barrier alterations in experimental animal models of neuropathy. Exp Neurol. 1985 Nov; 90(2):365-72. 1049479
    View PubMed
90. Poduslo JF, Windebank AJ. Differentiation-specific regulation of Schwann cell expression of the major myelin glycoprotein. Proc Natl Acad Sci U S A. 1985 Sep; 82(17):5987-91. 1050641
    View PubMed
91. Poduslo JF, Yao JK. Association and release of the major intrinsic membrane glycoprotein from peripheral nerve myelin. Biochem J. 1985 May 15; 228(1):43-54. 1050570
    View PubMed
92. Poduslo JF, Low PA, Nickander KK, Dyck PJ. Mammalian endoneurial fluid: collection and protein analysis from normal and crushed nerves. Brain Res. 1985 Apr 15; 332(1):91-102. 1048779
    View PubMed
93. Poduslo JF. Posttranslational protein modification: biosynthetic control mechanisms in the glycosylation of the major myelin glycoprotein by Schwann cells. J Neurochem. 1985 Apr; 44(4):1194-206. 1050557
    View PubMed
94. Poduslo JF, Dyck PJ, Berg CT. Regulation of myelination: Schwann cell transition from a myelin-maintaining state to a quiescent state after permanent nerve transection. J Neurochem. 1985 Feb; 44(2):388-400. 1048574
    View PubMed
95. Poduslo JF, Berg CT, Ross SM, Spencer PS. Regulation of myelination: axons not required for the biosynthesis of basal levels of the major myelin glycoprotein by Schwann cells in denervated distal segments of the adult cat sciatic nerve. J Neurosci Res. 1985; 14(2):177-85. 1050581
    View PubMed
96. Poduslo JF, Berg CT, Dyck PJ. Schwann cell expression of a major myelin glycoprotein in the absence of myelin assembly. Proc Natl Acad Sci U S A. 1984 Mar; 81(6):1864-6. 1118793
    View PubMed
97. Kishishita M, Luka J, Vroman B, Poduslo JF, Pearson GR. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen. Virology. 1984 Mar; 133(2):363-75. 1120595
    View PubMed
98. Poduslo JF. Regulation of myelination: biosynthesis of the major myelin glycoprotein by Schwann cells in the presence and absence of myelin assembly. J Neurochem. 1984 Feb; 42(2):493-503. 1120451
    View PubMed
99. Poduslo JF, Low PA, Windebank AJ, Dyck PJ, Berg CT, Schmelzer JD. Altered blood-nerve barrier in experimental lead neuropathy assessed by changes in endoneurial albumin concentration. J Neurosci. 1982 Oct; 2(10):1507-14. 1114379
    View PubMed
100. Low PA, Yao JK, Poduslo JF, Donald DE, Dyck PJ. Peripheral nerve microenvironment: collection of endoneurially enriched fluid. Exp Neurol. 1982 Jul; 77(1):208-14. 1114004
     View PubMed
101. Poduslo JF. Developmental regulation of the carbohydrate composition of glycoproteins associated with central nervous system myelin. J Neurochem. 1981 Jun; 36(6):1924-31. 1112593
     View PubMed
102. Reigner J, Matthieu JM, Kraus-Ruppert R, Lassmann H, Poduslo JF. Myelin proteins, glycoproteins, and myelin-released enzymes in experimental demyelination of the rabbit optic nerve: sequence of events. J Neurochem. 1981; 36:1986-1995. 1112686
     View PubMed
103. Poduslo JF. Glycoprotein molecular weight estimation using SDS-pore gradient electrophoresis: comparison of tris-glycine and tris-borate-EDTA buffer systems. Ann Biochem. 1981; 114:131-139. 1112687
     
104. Poduslo JF, Harman JL, McFarlin DE. Lectin receptors in central nervous system myelin. J Neurochem. 1980 Jun; 34(6):1733-44. 1110147
     View PubMed
105. Poduslo JF, Rodbard D. Estimation using sodium dodecyl sulfate-pore gradient electrophoresis. Anal Biochem. 1980; 101:394-406. 1109406
     View PubMed
106. Poduslo JF, McFarlin DE. Immunogenicity of a membrane surface glycoprotein associated with central nervous system myelin. Brain Res. 1978 Dec 22; 159(1):234-8. 1105545
     View PubMed
107. Poduslo JF. The molecular architecture of myelin: identification of the external surface membrane components. Adv Exp Med Biol. 1978; 100:189-205. 1105928
     View PubMed
108. Poduslo JF, Everly JL, Quarles RH. A low molecular weight glycoprotein associated with isolated myelin: distinction from myelin proteolipid protein. J Neurochem. 1977 May; 28(5):977-86. 1104065
     View PubMed
109. Poduslo JF, Quarles RH, Brady RO. External labeling of galactose in surface membrane glycoproteins of the intact myelin sheath. J Biol Chem. 1976 Jan 10; 251(1):153-8. 1102657
     View PubMed
110. Matthieu JM, Quarles RH, Poduslo JF, Brady RO. 35S-sulfate incorporation into myelin glycoproteins I. Central nervous system. Biochim Biophys Acta. 1975; 392:159-166. 1101180
     View PubMed
111. Poduslo JF, Braun PE. Topographical arrangement of membrane proteins in the intact myelin sheath. J Biol Chem. 1975; 250:1099-1105. 1101181
     View PubMed
112. Poduslo JF, Greenberg CS, Glick MC. Proteins exposed on the surface of mammalian membranes. Biochemistry. 1972 Jul 4; 11(14):2616-21. 1096402
     View PubMed
113. Suzuki K, Poduslo JF, Poduslo SE. Further evidence for a specific ganglioside fraction closely associated with myelin. Biochim Biophys Acta. 1968 May 1; 152(3):576-86. 1090781
     View PubMed